Browsing Tag
United States
1071 posts
Sun Pharmaceutical (SUNPHARMA) gains US approval for ILUMYA as Q2 profit falls 36%
Sun Pharmaceutical Industries has secured United States regulatory approval to expand ILUMYA into active psoriatic arthritis, strengthening its innovative medicines portfolio. The approval coincides with double-digit quarterly revenue growth but a sharp decline in reported profit, leaving product commercialisation and acquisition integration as important financial tests.
NABEP expands Maracaibo and Orinoco operations after first U.S. oil shipment as production growth accelerates
North American Blue Energy Partners expects its Venezuelan rig fleet to reach 41 units during November after reporting production of 223,509 barrels of oil equivalent per day. The expansion follows a U.S.-backed agreement covering 17 oilfields, but equipment commissioning, field rehabilitation and financing remain central to the company's ambition to exceed one million barrels of daily oil production.
South Korea exports surge 93.7% to $115.28bn as AI chip shipments triple
South Korea's exports surged 93.7% year-on-year to $115.28 billion in October 2026, driven by exceptional semiconductor and computer shipments. The increase was the strongest in more than five decades, although additional working days also contributed to the sharp annual comparison.
Chevron (CVX) profit surges to $9.9bn as refining boom offsets lower oil production
Chevron's third-quarter results show an exceptional improvement in downstream profitability and cash generation, even as oil and gas production declined from the previous year.
Perrigo (PRGO) agrees to sell $380m infant formula business for $40m upfront as impairment looms
Perrigo has agreed to sell its US infant formula business to MeridianMade for up to $175 million, although only $40 million is payable at closing. The planned divestiture could improve margins and reduce future manufacturing investment, but a substantial impairment charge and weak growth in its remaining consumer health business complicate the turnaround.
Pilgrim’s Pride (PPC) Q3 operating profit falls 61% despite Just Bare sales growth as chicken prices weaken
Pilgrim's Pride Corporation reported sharply lower quarterly earnings as increasing US poultry supply pressured commodity prices, exposing the limits of its growing branded prepared-food business in protecting overall profitability.
Platinum Equity to acquire Energy Distribution Partners after 45 acquisitions and threefold EBITDA growth
Platinum Equity has agreed to acquire Energy Distribution Partners, a US propane distributor built through 45 acquisitions and operating across 24 states. The proposed transaction follows a period of substantial earnings growth under PPC ownership, but further expansion will depend on acquisition economics, operating efficiency and maintaining local customer relationships.
Senores Pharmaceuticals (SENORES) targets 3.2bn annual manufacturing units, yet 50% to 70% utilisation raises a bigger question
Senores Pharmaceuticals Limited has announced â‚ą43 crore of manufacturing capacity investments across the United States and India, alongside quarterly revenue growth of nearly 25% and improved operating margins. However, the stock's 14.4% decline across two trading sessions has drawn attention to capacity utilisation, cash conversion and the company's ability to commercialise its growing pharmaceutical portfolio.
Aspen Neuroscience (ASPE) prices $140.6m IPO at $15 as Parkinson’s therapy enters pivotal development phase
Aspen Neuroscience has priced its Nasdaq initial public offering at $15 per share, the bottom of its proposed range, as it prepares to advance the investigational Parkinson's disease cell therapy sasineprocel into Phase 3 testing. The financing extends the company's expected operating runway into the second half of 2028, but its clinical programme remains expensive, and the company expects to require additional capital before development is complete.
CDC expands Ebola travel restrictions as airlines challenge sweeping new US entry rule
Every international passenger flying to the US will face a new Ebola declaration from November 3. Find out why airlines are challenging the CDC rule.